Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 165

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 165
---
 in Rule 430B, for liability purposes of the issuer and any        
 person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating       
 to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall      
 be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus   
 that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration       
 statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such      
 effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration 
 statement or made in any such document immediately prior to such effective date.                                                              |

| (6) | That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser                                   
 in the initial distribution of securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned 
 registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser,      
 if the securities are offered and sold to each purchaser by means of any of the following communications, the undersigned registrant will    
 be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:                                      |

| (i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required 
 to be filed pursuant to Rule 424;                                                                        |

| (ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant 
 or used or referred to by the undersigned registrant;                                                       |

| (iii) | The portion of any other free writing prospectus relating to the offering prepared by or on behalf of 
 the undersigned registrant; and                                                                       |

| (iv) | Any other communications that is an offer in the offering made by the undersigned registrant to the purchaser. |

| (b) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,                                       
 officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised           
 that in the opinion of the Securities and Exchange Commission such indemnification is against public